Press release
Kidney Cancer Diagnostics And Therapeutics Market Insights 2025-2034: Growth Forecast and Strategic Priorities
Kidney Cancer Diagnostics And Therapeutics
Kidney Cancer Diagnostics And Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for kidney cancer diagnostics and therapeutics has significantly expanded in the past few years. The market, estimated at $4.1 billion in 2024, is projected to increase to $4.32 billion in 2025, marking a compound annual growth rate (CAGR) of 5.4%. This substantial growth during the historical timeframe is the result of advancements in molecular biology research, clinical trials, new drug developments, surgical innovations, genetic findings, and improvements in healthcare access.
Kidney Cancer Diagnostics And Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
Predictions indicate a promising expansion for the kidney cancer diagnostics and therapeutics market in the upcoming years. By 2029, the market is expected to reach $5.68 billion, with a compound annual growth rate (CAGR) of 7.0%. This potential growth is underpinned by several factors such as advances in biomarker research, genomic sequencing, telemedicine, and precision medicine, alongside the implementation of rapid diagnostic technologies. The forecast period also foresees significant trends like the adoption of palliative care integration, comprehensive survivorship care, lifestyle and nutrition intervention, wide application of radiomics, and increasing acceptance of liquid biopsies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report
What Are the Drivers Transforming the Kidney Cancer Diagnostics And Therapeutics Market?
It is anticipated that the growth of the kidney cancer diagnostics and therapeutics market will be propelled by the rising incidence of kidney cancer. This disease is characterized by abnormal cell changes and unchecked growth in one or both kidneys, resulting in a renal cortical tumor. The significance of kidney cancer diagnostics and therapeutics is underscored by their advantages, including early disease detection, precise diagnosis, personalized medicine, treatment choice, and tracking. For example, the American Society of Clinical Oncology (ASCO), a US-based non-profit committed to cancer care, estimates that in the United States, 81,800 people (52,360 men and 29,440 women) will be diagnosed with kidney cancer in March 2023. Furthermore, globally, kidney cancer impacted 431,288 individuals in 2020. As such, the escalating incidence of kidney cancer is predicted to fuel the expansion of the kidney cancer diagnostics and therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp
What Long-Term Trends Will Define the Future of the Kidney Cancer Diagnostics And Therapeutics Market?
A key focus for leading firms in the kidney cancer diagnostics and therapeutics market is the progression of advanced renal cell carcinoma (RCC) treatments. The aim is to revolutionize treatment choices fitting the specific requirements of patients battling this diagnostic challenge. Renal cell carcinoma (RCC) research plays a pivotal role in the kidney cancer diagnostics and therapeutics realm due to its potential to generate enhanced diagnostic practices and precision therapies. Such developments heighten the chances of early diagnosis and personalized treatment for patients. Merck, a significant US-based pharmaceutical enterprise, is a case in point. In December 2023, it introduced welireg (belzutifan), the pioneer hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor sanctioned for adult patients with advanced renal cell carcinoma (RCC) previously treated with PD-1 or PD-L1 inhibitors and VEGF-TKIs. This unique therapeutic category offers considerable advantages, such as improved progression-free survival and increased response rates compared to everolimus. The approval of WELIREG symbolizes an essential breakthrough in the kidney cancer diagnostics and therapeutics market, providing renewed optimism for patients with advancing disease.
Which Segments in the Kidney Cancer Diagnostics And Therapeutics Market Offer the Most Profit Potential?
The kidney cancer diagnostics and therapeutics market covered in this report is segmented -
1) By Cancer Type: Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types
2) By Component: Drugs, Diagnostics
3) By Diagnostics: Biopsy, CT Scan, Nephro-Ureteroscopy, Intravenous Pyelogram, Ultrasound
4) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy
5) By End-Users: Hospitals, Pharmaceutical Labs, Genomics Laboratories
Subsegments:
1) By Clear Cell RCC: Stage I, Stage II, Stage III, Stage IV
2) By Papillary RCC: Type 1, Type 2
3) By Chromophobe RCC: Localized, Advanced
4) By Urothelial Carcinoma And Transitional Cell Carcinoma: Non-muscle invasive, Muscle invasive, Metastatic
5) By Other Cancer Types: Collecting Duct Carcinoma, Renal Medullary Carcinoma, Other rare types
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11937&type=smp
Which Firms Dominate the Kidney Cancer Diagnostics And Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the kidney cancer diagnostics and therapeutics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Pharmaceuticals Limited, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Eisai Co. Ltd., Illumina Inc., PerkinElmer Inc., Ipsen S.A, Bio-Rad Laboratories Inc., QIAGEN NV, Exelixis Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., GeneDx LLC, CD Genomics, Genpath Life Sciences Private Limited
Which Regions Offer the Highest Growth Potential in the Kidney Cancer Diagnostics And Therapeutics Market?
North America was the largest region in the kidney cancer diagnostics and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney cancer diagnostics and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11937
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics And Therapeutics Market Insights 2025-2034: Growth Forecast and Strategic Priorities here
News-ID: 4108104 • Views: …
More Releases from The Business Research Company
Comprehensive Seed Coating Materials Market Forecast 2025-2034: Growth Trends an …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Seed Coating Materials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for seed coating materials has experienced swift expansion. It's projected to increase from $2.41 billion in 2024 to $2.65 billion in 2025, boasting a compound annual growth rate…
Rising Construction Activities Fuels Lighting Control System Market Growth: Powe …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Lighting Control System Market Through 2025?
Rapid growth has been observed in the lighting control system market size in recent years. The market which was valued at $42.64 billion in 2024, is expected to reach $50.1 billion in 2025, showcasing a compound…
Emerging Trends to Reshape the SCM Software Market: Home Depot's Centralization …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
SCM Software Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Rapid expansion has been observed in recent years in the market size of SCM software. This market is predicted to rise from $58.5 billion in 2024 to a whopping $64.98 billion in 2025, showing a…
Navigating The Growth Of SATCOM Transceivers In An Era Of Space Expansion: A Key …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
SATCOM On The Move Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for "satcom on the move" has been experiencing speedy growth lately. As per predictions, it's supposed to rise from $29.43 billion in 2024 to approximately $34.89 billion in 2025, with…
More Releases for Cancer
Global Stomach Cancer And Gastric Cancer Treatment Market Size by Application, T …
The growth of the stomach cancer and gastric cancer treatment market is primarily driven by the increasing global incidence of gastric cancer, which is one of the leading causes of cancer-related deaths worldwide. Factors such as unhealthy eating habits, smoking, and family history contribute to the rise in gastric cancer cases. Additionally, advances in treatment options, including targeted therapies, immunotherapy, and novel combination regimens, are transforming the landscape of gastric…
Anti-Cancer MAbS Market Witness Highest Growth in near future| Leading Key Playe …
Anti-Cancer MAbS Market 2023 Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Anti-Cancer MAbS industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and…
Exosome Research Products Market by Product and Services (Kit, Reagent, Instrume …
The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is…
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Cancer Immunotherapy Market Value to grasp $117.11 billion by 2022, at CAGR of 1 …
Monoclonal Antibodies are expected to dominate the global cancer immunotherapy market during the forecast period, owing to the rise in adoption and high usage of monoclonal antibody for cancer immunotherapy as these antibodies are specific to the antigen expressed by tumor itself.
The global cancer immunotherapy market was valued at $45,471 million in 2015, and is projected to reach $117,114 million by 2022, growing at a CAGR of 14.5% from 2016…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
